Peter Rahal, Co-founder and CEO of RXBar, says the company was founded on the transparency of its ingredients, and that purpose led to a $600 million buyout from Kellogg.
Rahal explains why ever ingredient in every product is in bold letters on the front of the package. When the company started out, "people would be like ‘well what is it?'” So they made the answer easy to find.
Rahal discusses RXBAR's $600 million sale to Kellogg, and the future direction of the company, where he will remain as CEO. We talk about the whirlwind the company's evolution has been, given that it was founded in 2013, when Rahal and his co-founder were both broke. Then we look ahead to what's next for the company after the Kellogg buyout.
Movie studios are comfortable digging through comic bins for hot new intellectual property, but they are not comfortable returning the favor and sharing th
Chris Versace, CIO at Tematica Research and portfolio manager for TheStreet Pro, joins from the NYSE to break down the Fed’s latest move and Big Tech’s earnings
Sabrina Siddiqui, National Politics Reporter at The Wall Street Journal, joins to break down the SNAP funding delays and the human cost of the ongoing shutdown.
Arguments at the Supreme Court have concluded for the day as the justices consider President Donald Trump's sweeping unilateral tariffs in a trillion-dollar test of executive power.
AI is reshaping investigations. Longeye CEO Guillaume Delepine shares how their AI workspace empowers law enforcement to uncover insights faster and smarter.
Stephen Kates, Financial Analyst at Bankrate, joins to discuss the Fed’s 25-basis-point rate cut, inflation risks, and what it all means for consumers and marke
Big tech earnings take center stage as investors digest results from Alphabet, Meta, Microsoft, Amazon, and Apple, with insights from Gil Luria of D.A. Davidson
